Isoniazid, known as isonicotinic acid hydrazide, is an antibiotic used for the treatment of tuberculosis.
FactSnippet No. 971,880 |
Isoniazid, known as isonicotinic acid hydrazide, is an antibiotic used for the treatment of tuberculosis.
FactSnippet No. 971,880 |
Isoniazid is often used to treat latent and active tuberculosis infections.
FactSnippet No. 971,881 |
Isoniazid has been approved as prophylactic therapy for the following populations:.
FactSnippet No. 971,882 |
Isoniazid can be used alone or in combination with Rifampin for treatment of latent tuberculosis, or as part of a four-drug regimen for treatment of active tuberculosis.
FactSnippet No. 971,883 |
Isoniazid was widely used in the treatment of Mycobacterium avium complex as part of a regimen including rifampicin and ethambutol.
FactSnippet No. 971,884 |
Isoniazid has a boxed warning for severe and sometimes fatal hepatitis, which is age-dependent at a rate of 0.
FactSnippet No. 971,885 |
Isoniazid is associated with pyridoxine deficiency because of its similar structure.
FactSnippet No. 971,886 |
Isoniazid was found to significantly elevate the in vivo concentration of GABA and homocarnosine in a single subject via magnetic resonance spectroscopy.
FactSnippet No. 971,887 |
Isoniazid is thought to induce a liver enzyme which causes a larger amount of acetaminophen to be metabolized to a toxic form.
FactSnippet No. 971,888 |
Isoniazid is a prodrug that inhibits the formation of the mycobacterial cell wall.
FactSnippet No. 971,889 |
Isoniazid must be activated by KatG, a bacterial catalase-peroxidase enzyme in Mycobacterium tuberculosis.
FactSnippet No. 971,890 |
Isoniazid is bactericidal to rapidly dividing mycobacteria, but is bacteriostatic if the mycobacteria are slow-growing.
FactSnippet No. 971,891 |